StockData
Kazia Therapeutics Ltd logo

Kazia Therapeutics Ltd (KZIA) stock

KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$4.92−0.45 (-8.38%)

Close on Nov 20, 2026Market cap $7.96MP/E –Yield –

Kazia Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was A$42.00K, down 98.2% from the year before. The highest annual figure on record is A$15.18M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Jun 30, 2025A$42.00K-98.2%
FY2024Jun 30, 2024A$2.31M–
FY2023Jun 30, 2023A$0–
FY2022Jun 30, 2022A$0-100.0%
FY2021Jun 30, 2021A$15.18M+12658.8%
FY2018Jun 30, 2018A$119.00K-52.2%
FY2017Jun 30, 2017A$249.00K-38.7%
FY2016Jun 30, 2016A$406.00K–

More Kazia Therapeutics figures

See a number that looks wrong?